Literature DB >> 10326294

Re-emergence of monkeypox in Africa: a review of the past six years.

D L Heymann1, M Szczeniowski, K Esteves.   

Abstract

Human monkeypox was first identified in 1970 in the Democratic Republic of the Congo. Extensive studies of this zoonotic infection in the 1970s and 1980s indicated a largely sporadic disease with a minority of cases resulting from person-to-person transmission, rarely beyond two generations. In August 1996, an unusually large outbreak of human monkeypox was reported, and cases continued through 1997 with peak incidence in August 1996, March 1997 and August 1997. Preliminary results from the field investigations in 1997 suggest a new epidemiological pattern where a majority of secondary cases result from person-to-person transmission, and a clinically milder disease. But there is preliminary laboratory evidence of a simultaneous outbreak of varicella in the same geographic region which will undoubtedly modify these preliminary results. Since smallpox was eradicated and vaccinia vaccination terminated in this region, the population of susceptible individuals has grown. The use of vaccination to protect the population at risk, however, must take into account HIV prevalence and the risk of generalized vaccinia when using vaccinia vaccine in populations where HIV is known to be present.

Entities:  

Mesh:

Year:  1998        PMID: 10326294     DOI: 10.1093/oxfordjournals.bmb.a011720

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  59 in total

1.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

2.  Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection.

Authors:  Ryan D Estep; Ilhem Messaoudi; Megan A O'Connor; Helen Li; Jerald Sprague; Alexander Barron; Flora Engelmann; Bonnie Yen; Michael F Powers; John M Jones; Bridget A Robinson; Beata U Orzechowska; Minsha Manoharan; Alfred Legasse; Shannon Planer; Jennifer Wilk; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Evaluation of monkeypox disease progression by molecular imaging.

Authors:  Julie Dyall; Reed F Johnson; Dar-Yeong Chen; Louis Huzella; Dan R Ragland; Daniel J Mollura; Russell Byrum; Richard C Reba; Gerald Jennings; Peter B Jahrling; Joseph E Blaney; Jason Paragas
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

4.  Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey.

Authors:  Noriyo Nagata; Masayuki Saijo; Michiyo Kataoka; Yasushi Ami; Yuriko Suzaki; Yuko Sato; Naoko Iwata-Yoshikawa; Momoko Ogata; Ichiro Kurane; Shigeru Morikawa; Tetsutaro Sata; Hideki Hasegawa
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  CD4 and CD8 T cells participate in the immune memory response against Vaccinia virus after a previous natural infection.

Authors:  Daniela Carla Medeiros-Silva; Eduardo Augusto Dos Santos Moreira-Silva; Juliana de Assis Silva Gomes; Flávio Guimarães da Fonseca; Rodrigo Correa-Oliveira
Journal:  Results Immunol       Date:  2013-11-09

Review 6.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

7.  Evolutionary entropy determines invasion success in emergent epidemics.

Authors:  Christopher J Rhodes; Lloyd Demetrius
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

8.  Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001.

Authors:  Hermann Meyer; Mathilde Perrichot; Markus Stemmler; Petra Emmerich; Herbert Schmitz; Francis Varaine; Robert Shungu; Florimond Tshioko; Pierre Formenty
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.

Authors:  Debra C Quenelle; Deborah J Collins; Earl R Kern
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Nested-multiplex PCR detection of Orthopoxvirus and Parapoxvirus directly from exanthematic clinical samples.

Authors:  Jônatas S Abrahão; Larissa S Lima; Felipe L Assis; Pedro A Alves; André T Silva-Fernandes; Marcela M G Cota; Vanessa M Ferreira; Rafael K Campos; Carlos Mazur; Zélia I P Lobato; Giliane S Trindade; Erna G Kroon
Journal:  Virol J       Date:  2009-09-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.